Table 1.

Percent Recovery of Peripheral Blood Lymphocyte Subsets During and After Intensive Chemotherapy

TimepointCD4+CD8+CD8+CD3+B CellsNK Cells
Pretherapy* 100 100 100 100 100 
Nadir 16 ± 3 27 ± 5 26 ± 6 3 ± 2 27 ± 25 
3 mos 35 ± 7 98 ± 24 113 ± 34 164 ± 43 86 ± 18 
6 mos 49 ± 9 89 ± 11 94 ± 15 197 ± 28 94 ± 28 
9 mos 48 ± 12 105 ± 23 109 ± 29 191 ± 41 148 ± 71 
12 mos 78 ± 19 85 ± 16 84 ± 16 124 ± 30 69 ± 15 
TimepointCD4+CD8+CD8+CD3+B CellsNK Cells
Pretherapy* 100 100 100 100 100 
Nadir 16 ± 3 27 ± 5 26 ± 6 3 ± 2 27 ± 25 
3 mos 35 ± 7 98 ± 24 113 ± 34 164 ± 43 86 ± 18 
6 mos 49 ± 9 89 ± 11 94 ± 15 197 ± 28 94 ± 28 
9 mos 48 ± 12 105 ± 23 109 ± 29 191 ± 41 148 ± 71 
12 mos 78 ± 19 85 ± 16 84 ± 16 124 ± 30 69 ± 15 
*

Mean pretherapy values (CD4+: 807 ± 152, CD8+: 641 ± 139, CD8+CD3+: 520 ± 123, B: 215 ± 50, NK: 262 ± 56 cells/μL) are arbitrarily designated as 100%. Percent change was calculated for individual patients by dividing the values obtained at each timepoint specified by the pretherapy value × 100. Mean percent change and SEM for all patients studied is shown.

Nadir is defined as the timepoint when the lowest counts for each individual subset was recorded. This generally occurred at or near the completion of chemotherapy.

P < .05 when compared with percent change for CD4+ cells at the same timepoint using Wilcoxon Signed Rank Test.

Close Modal

or Create an Account

Close Modal
Close Modal